(5) MAPT-AS1 has been identified as a solid prognostic marker of renal clear cell carcinoma (ccRCC), inhibiting the invasion and proliferation of ccRCC [19]. The gene discussed is MAPT; the disease is nonpapillary renal cell carcinoma.